human biosynthetic insulin dna recombinant

Ukraine

Drugs containing this active substance

  • PHARMASULIN® H NP

    The drug is intended for the treatment of patients with diabetes mellitus who require insulin administration to maintain normal blood glucose levels.

    Form: suspension for injection

    Active substance Dosage
    human biosynthetic insulin dna recombinant 100 IU/ml

    ATC: A10AC01

    Manufacturer: Farmak JSC